INSMED Inc — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-07-08

Reporting Person: Smith Michael Alexander (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-08	Common Stock	A	6722	—	Acquired	29228	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Stock Option (right to buy)	$27.89	A	32550	Acquired	2031-07-08	Common Stock (32550)	Direct

Footnotes

F1: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2: Each Restricted Stock Unit was received as a grant on July 8, 2021, for no consideration.

F3: In connection with the appointment of Mr. Smith as the Company's General Counsel, Senior Vice President, the Company granted Mr. Smith an option to purchase a total of 32,550 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Smith's continued employment with the Company on each vesting date.